Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Opal, a digital e-commerce ...

The Opal platform offers eye care professionals a complementary tool for patients, featuring order tracking, appointment ...

Opal is an all-in-one digital platform that offers faster, more convenient ordering of Bausch + Lomb products, helping to ...

Bausch + Lomb BLCO shares ended the last trading session 14.5% higher at $17.80. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Eyecare company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial Times reported The stock of eyecare company Bausch + Lomb Corp. was up 14%on ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bausch + Lomb, one of the world’s largest contact lens suppliers, is exploring a sale as a way to clean ...

As part of the deal, Bausch + Lomb will help scale commercialization of Trukera’s ScoutPro Osmolarity System, a device that measures tear osmolarity, or the salt content of a person’s tears, to help ...

Bausch Health retained an 88% stake in Bausch + Lomb after listing the subsidiary in 2022 and had planned to exchange the remaining shares for Bausch Health stock. However, concerns arose about ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Your bid or registration is pending approval with the auctioneer. Please check your email account for more details. Unfortunately, your registration has been declined by the auctioneer. You can ...